Nisa Investment Advisors
CRDF icon

Nisa Investment Advisors’s Cardiff Oncology CRDF Stock Holding History

Nisa Investment Advisors’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$203 Buy
+125
New +$257 ﹤0.01% 2988
2025
Q4 		– Sell
-209
Closed -$431 – 2993
2025
Q3 		$431 Sell
209
-4,700
-96% -$13K ﹤0.01% 2872
2025
Q2 		$15.5K Buy
4,909
+3,766
+329% +$11.5K ﹤0.01% 2066
2025
Q1 		$3.59K Buy
1,143
+906
+382% +$3.58K ﹤0.01% 2324
2024
Q4 		$1.03K Buy
237
+215
+977% +$672 ﹤0.01% 2676
2024
Q3 		$59 Buy
+22
New +$52 ﹤0.01% 2928
2022
Q2 		– Sell
-2,130
Closed -$5K – 2391
2022
Q1 		$5K Sell
2,130
-3,200
-60% -$11.3K ﹤0.01% 2308
2021
Q4 		$18K Sell
5,330
-1,670
-24% -$9.95K ﹤0.01% 1933
2021
Q3 		$47 Buy
+7,000
New +$44K ﹤0.01% 1948

Other funds holding CRDF

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
FLPIM
F.L. Putnam Investment Management Lynnfield, Massachusetts $8.39B AUM 37.75% 1-Year Est. Return

Nisa Investment Advisors's CRDF Position: Q1 2026 in Review

Nisa Investment Advisors opened a new position in Cardiff Oncology (CRDF) in Q1 2026: 125 shares worth $203. The stake represents ﹤0.01% of the portfolio and ranks #2988 among its holdings. This is a return to the name: Nisa Investment Advisors previously reported a position in CRDF as recently as Q3 2025.

Nisa Investment Advisors first reported a position in CRDF in Q3 2021 and has held it in 9 quarters since. The position peaked at $18K in Q4 2021. 117 funds tracked by Wall St. Rank hold CRDF as of Q1 2026.

  • Nisa Investment Advisors held 125 shares of Cardiff Oncology worth $203 as of Q1 2026.
  • Cardiff Oncology was a new Nisa Investment Advisors position in Q1 2026.
  • Cardiff Oncology made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q1 2026, its #2988 holding.
  • Nisa Investment Advisors first reported a position in Cardiff Oncology in Q3 2021 and has held it in 9 quarters since.
  • Nisa Investment Advisors's Cardiff Oncology position peaked at $18K in Q4 2021.
  • 117 funds tracked by Wall St. Rank held Cardiff Oncology as of Q1 2026.

Based on Nisa Investment Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.